Insider trades
Stock that executives, directors and 10% owners bought and sold on the open market, from the Form 4s they file with the SEC within two business days. Grants, option exercises and shares sold to cover taxes are left out.
- $79.2M bought by 61 insiders at 47 companies
- $239M sold by 49 insiders outside a trading plan
- $2.5B sold by 203 insiders under 10b5-1 plans
- 10 companies where two or more insiders bought (30 days)
Biggest buys
Past week, each insider's filings added up.
-
CRBGCorebridge FinancialLife Insurance Co Nippon10% owner$49.2M
-
DOLEDole PLCPale Fire Capital SE10% owner, +4 joint filers$8.6M
-
APLDApplied DigitalJason Gechen ZhangPresident$5.7M
-
RENTRent the RunwaySTORY3 Capital Partners, LLCDirector, +3 joint filers$2.2M
-
RENTRent the RunwayCHS US Investments LLC10% owner, +4 joint filers$1.6M
-
FBKFB FinancialOrrin H Ingram IIDirector$1.5M
-
TENXTenax TherapeuticsADAR1 Capital Management, LLC10% owner, +1 joint filer$1.5M
-
APLDApplied DigitalWes CumminsCEO$1M
-
RAPPRapport TherapeuticsSteven M PaulDirector$974K
-
SNESSenesTechGlenbrook Capital Management10% owner$781K
Biggest sales
Past week, each insider's filings added up. Planned sales are marked.
-
IHTInnSuites Hospitality TrustJames F WirthCEO$2B
-
SNOWSnowflakeFrank SlootmanDirector$94.9M
-
TALOTalos EnergyEmpresarial De Capitales S.a. De C.v. Control10% owner$85.9M
-
TRVTravelersAlan D SchnitzerCEO$35.3M
-
PATHUiPathDaniel DinesCEO$33.1M
-
UTHRUnited TherapeuticsMartine A RothblattCEO$26.4M
-
MUMicron TechnologyScott J DeboerPres. & Chief Tech & Prod Offr$25.7M
-
ALMRAlamar BiosciencesQiming Corporate GP VI, Ltd.10% owner, +6 joint filers$21M
-
SNOWSnowflakeBenoit DagevilleDirector$16.1M
-
LINDLindblad ExpeditionsSven-Olof LindbladDirector$14.3M
Cluster buying
Companies where two or more insiders bought on the open market in the last 30 days, most buyers first
-
Che-Chia Wei CEO, Yuh-Jier Mii COO, Yung-Pei Chin COO, Yung-Chin Hou COO, +15 more
-
Reuben S Leibowitz Director, Larry C Glasscock Director, Daniel C. Smith Director, Gary M Rodkin Director, +7 more
-
R Jeffrey Bailly Director, Daniel L Florness Director, Srilata Zaheer Director, Charles T Lauber Director, +5 more
-
Steven M Paul Director, John Maraganore Director, Troy A. Ignelzi CFO, Wendy B. Young Director, +2 more
-
Thomas Jon Hammond Director, Sandip I Patel CFO, John Martin Schaible Chair, David Craig Ridenhour President, +1 more
-
John B Williamson III Director, Robert B Johnston Director, Paul W Nester CEO, Lawrence T. Oliver Senior VP and Secretary, +1 more
-
Michael Jordan Osborn CEO, John Walter Hazlett CFO, Gregory William Voorhies Director, James W Bernau President, +1 more
-
Matthew G De Soto Director, Albert J. Evans Director, Joel L. Frank Director, Theodore W Mowery Director, +1 more
-
Smriti Laxman Popenoe CEO, Byron L Boston CEO, Terrence John Connelly Jr. Chief Investment Officer, Michael Andrew Sartori CFO
-
Lewis H Titterton Jr. Director, Amit Kumar CEO, Michael Catelani CFO, Arnold M Baskies Director
NTHI insider trades
Every open-market buy and sale in NTHI, one row per filing, newest first
-
Amir F Heshmatpour CEONTHINeOnc TechnologiesBuy$175K 50,000 shares at $3.50 +1.6% to stakeTraded Sep 14–15 Filed Sep 15
-
Thomas C Chen CEONTHINeOnc TechnologiesBuy$40K 10,798 shares at $3.70 +79% to stakeTraded Sep 11–14 Filed Sep 15
-
Keithly Garnett CFONTHINeOnc TechnologiesBuy$1,001 257 shares at $3.89 +0.1% to stakeTraded Sep 14 Filed Sep 15
-
Amir F Heshmatpour CEONTHINeOnc TechnologiesBuy$136K 37,000 shares at $3.67 +1.2% to stakeTraded Sep 11 Filed Sep 14
-
Thomas C Chen CEONTHINeOnc TechnologiesBuy$70K 12,757 shares at $5.49 +1346% to stakeTraded Aug 18 Filed Aug 20
-
Thomas C Chen Chief Scientific OfficerNTHINeOnc TechnologiesBuy$193K 47,207 shares at $4.09Traded Apr 10–Aug 17 Filed Aug 20
-
Amir F Heshmatpour CEONTHINeOnc TechnologiesBuy$50K 9,000 shares at $5.54 +0.3% to stakeTraded Aug 18 Filed Aug 18
-
Amir F Heshmatpour CEONTHINeOnc TechnologiesBuy$59K 15,000 shares at $3.91 +0.5% to stakeTraded Aug 14–17 Filed Aug 17
-
Amir F Heshmatpour PresidentNTHINeOnc TechnologiesBuy$42K 10,000 shares at $4.16 +0.3% to stakeTraded May 1 Filed May 4
-
Amir F Heshmatpour PresidentNTHINeOnc TechnologiesBuy$45K 10,000 shares at $4.52 +0.3% to stakeTraded Apr 28 Filed Apr 28
-
Yousha Neman-Ebrahim Chief Clinical OfficerNTHINeOnc TechnologiesBuy$2,440 500 shares at $4.88 +0.4% to stakeTraded Apr 23 Filed Apr 24
-
Keithly Garnett CFONTHINeOnc TechnologiesBuy$1,614 300 shares at $5.38 +0.1% to stakeTraded Apr 15, 2025 Filed Apr 24
-
Amir F Heshmatpour PresidentNTHINeOnc TechnologiesBuy$49K 10,000 shares at $4.90 +0.3% to stakeTraded Apr 23 Filed Apr 23
-
David Suh Jr. Chief Accounting OfficerNTHINeOnc TechnologiesBuy$1,000 200 shares at $5.00 +0.2% to stakeTraded Apr 9 Filed Apr 13
-
Amir F Heshmatpour PresidentNTHINeOnc TechnologiesBuy$49K 10,000 shares at $4.90 +0.3% to stakeTraded Apr 10 Filed Apr 10
-
Amir F Heshmatpour PresidentNTHINeOnc TechnologiesBuy$82K 15,000 shares at $5.47 +0.5% to stakeTraded Apr 8–9 Filed Apr 9
-
Amir F Heshmatpour PresidentNTHINeOnc TechnologiesBuy$153K 25,000 shares at $6.14 +0.8% to stakeTraded Apr 2–6 Filed Apr 6
-
Amir F Heshmatpour PresidentNTHINeOnc TechnologiesBuy$185K 30,000 shares at $6.16Traded Nov 21–24 Filed Nov 24, 2025
-
Yousha Neman-Ebrahim Chief Clinical OfficerNTHINeOnc TechnologiesBuy$7,359 1,100 shares at $6.69 +0.8% to stakeTraded Nov 20, 2025 Filed Nov 24, 2025
About this data
- Officers, directors and anyone owning more than 10% of a company must report a trade in its stock on a Form 4 within two business days. We read each filing from SEC EDGAR and link to it on every row.
- Only open-market purchases and sales of common stock count here. Stock grants, option exercises, gifts and shares withheld or sold to pay taxes on vesting awards are not decisions to buy or sell, so they are left out.
- A planned sale was made under a Rule 10b5-1 trading plan, which the insider set up months in advance. Many executives sell this way on a schedule, so a planned sale says less than one made on the day.
- Values are shares times the price reported. When a filing amends an earlier one, the amended trades replace the originals. Related owners (a fund and its manager) who report the same trade separately are shown once.
- We cover the 4,841 US companies on our earnings calendar, with a year of history. The superinvestor notes count the featured 13F managers who added or cut the stock in their latest quarter.